These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

650 related items for PubMed ID: 4949305

  • 41. Crystal arthropathies: recognizing and treating "the gouch".
    Quillen DM.
    Prim Care; 2010 Dec; 37(4):703-11, v. PubMed ID: 21050952
    [Abstract] [Full Text] [Related]

  • 42. [Editorial: Therapy of gout nowadays (author's transl)].
    Mertz DP.
    Schweiz Rundsch Med Prax; 1974 Oct 08; 63(40):1185-7. PubMed ID: 4445089
    [No Abstract] [Full Text] [Related]

  • 43. Hyperuricemia and gout: an update.
    Khachadurian AK.
    Am Fam Physician; 1981 Dec 08; 24(6):143-8. PubMed ID: 6895439
    [Abstract] [Full Text] [Related]

  • 44. Allopurinol in primary gout with and after the administration of uricosuric agents.
    Kersley GD.
    Ann Rheum Dis; 1966 Nov 08; 25(6 Suppl):643-4. PubMed ID: 5958694
    [No Abstract] [Full Text] [Related]

  • 45. The use of the xanthine oxidase inhibitor, allopurinol, in the control of hyperuricaemia, gout and uric acid calculi.
    Emmerson BT.
    Australas Ann Med; 1967 Aug 08; 16(3):205-14. PubMed ID: 6056609
    [No Abstract] [Full Text] [Related]

  • 46. Update on emerging urate-lowering therapies.
    Chohan S, Becker MA.
    Curr Opin Rheumatol; 2009 Mar 08; 21(2):143-9. PubMed ID: 19339925
    [Abstract] [Full Text] [Related]

  • 47. [Study of the effects of benziodarone in 100 gouty patients during a diuresis cure: effects on uric acid and oxalic acid].
    Mugler A.
    Rein Foie; 1967 Mar 08; 10():273-92. PubMed ID: 6081455
    [No Abstract] [Full Text] [Related]

  • 48. Allopurinol (xanthine oxidase inhibitor) in the treatment of resistant gout.
    Bartels EC.
    JAMA; 1966 Nov 14; 198(7):708-12. PubMed ID: 5953324
    [No Abstract] [Full Text] [Related]

  • 49. [When and how to prescribe uricosuric agents? The need for urinary alkalinization].
    Lagrue G.
    Sem Hop Ther; 1974 Nov 14; 50(7-8):449-52. PubMed ID: 4445888
    [No Abstract] [Full Text] [Related]

  • 50. Long-term treatment of gout with "allopurinol".
    Michotte JL, Burtonboy G.
    Acta Rheumatol Scand; 1968 Nov 14; 14(1):71-8. PubMed ID: 5649436
    [No Abstract] [Full Text] [Related]

  • 51. Drugs for gout.
    Med Lett Drugs Ther; 2014 Mar 17; 56(1438):22-4. PubMed ID: 24791281
    [No Abstract] [Full Text] [Related]

  • 52. Pharmacokinetic and pharmacodynamic interaction between allopurinol and probenecid in patients with gout.
    Stocker SL, Graham GG, McLachlan AJ, Williams KM, Day RO.
    J Rheumatol; 2011 May 17; 38(5):904-10. PubMed ID: 21285173
    [Abstract] [Full Text] [Related]

  • 53. Approach to the treatment of hyperuricemia.
    Poon SH, Hall HA, Zimmermann B.
    Med Health R I; 2009 Nov 17; 92(11):359-62. PubMed ID: 19999894
    [No Abstract] [Full Text] [Related]

  • 54. Treatment of gout with allopurinol and sulphinpyrazone in combination and with allopurinol alone.
    Kuzell WC, Seebach LM, Glover RP, Jackman AE.
    Ann Rheum Dis; 1966 Nov 17; 25(6 Suppl):634-42. PubMed ID: 5335061
    [No Abstract] [Full Text] [Related]

  • 55. [Drug therapy of hyperuricemia].
    Gröbner W.
    Verh Dtsch Ges Inn Med; 1986 Nov 17; 92():492-7. PubMed ID: 3811551
    [No Abstract] [Full Text] [Related]

  • 56. [Hyperuricemia and gout; treatment of an acute attack of gout].
    Gast LF, Cats A, van Romunde LK.
    Ned Tijdschr Geneeskd; 1983 Dec 03; 127(49):2235-7. PubMed ID: 6656915
    [No Abstract] [Full Text] [Related]

  • 57. The influence of allopurinol on the course of gout. A study of 28 cases.
    Kawenoki-Minc E, Eyman E, Sopata I, Weryńska-Przybylska J.
    Reumatologia; 1970 Dec 03; 8(3):177-92. PubMed ID: 5469423
    [No Abstract] [Full Text] [Related]

  • 58. [The treatment of gout in the senile age].
    Silvi G, Pardini C.
    Policlinico Med; 1971 Dec 03; 78(5):222-8. PubMed ID: 5131996
    [No Abstract] [Full Text] [Related]

  • 59. Gout.
    Wyngaarden JB.
    Adv Metab Disord; 1965 Dec 03; 2():1-78. PubMed ID: 4924371
    [No Abstract] [Full Text] [Related]

  • 60. Management of gout.
    Gordon GV, Schumacher HR.
    Am Fam Physician; 1979 Jan 03; 19(1):91-7. PubMed ID: 760433
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 33.